Neuromodulation-based Patch for Migraine Relief
Company Founded Year
Company Number of Employees
Medical devices | Medical equipment
General wellbeing / wellness (users without clinical diagnosis)
Neuromodulation Interventions | Non-Invasive (TMS | tDCS | tACS)
Theranica is the developer of Nerivio, a fully integrated, self-contained family of therapeutic patches. The patches and other types of wearables in the companyâ€™s pipeline are controlled by smartphone applications to easily adapt therapy treatments to everyday life.
Theranicaâ€™s Nerivio Migra is a migraine-relief patch that provides migraine treatment through neuromodulation. Instead of placing electrodes on their head, patients can attach Theranicaâ€™s clinically tested, wearable patch on their arm and launch a personalized pain-relief program.
Theranica combines electrical neurostimulation and neuromuscular-stimulation technologies with modern wireless communication and smartphone applications. The company uses these advanced technologies to design and deliver effective products for treating a variety of severe and common medical problems.
In May 2019, Theranica won FDA De Novo clearance for its Nerivio Migra device. In June 2019, the company announced the establishment of a wholly owned subsidiary company, Theranica USA, headquartered in Montclair, New Jersey.
Nerivio appeared on TIMEâ€™s List of 100 Best Inventions of 2019. Theranica was also listed as one of 36 game-changing companies in 2020 by New York-based research firm CB Insights.